203 related articles for article (PubMed ID: 27915244)
1. Antifungal activity in vitro and in vivo of a salmon protamine peptide and its derived cyclic peptide against Candida albicans.
Nagao JI; Cho T; Mitarai M; Iohara K; Hayama K; Abe S; Tanaka Y
FEMS Yeast Res; 2017 Feb; 17(1):. PubMed ID: 27915244
[TBL] [Abstract][Full Text] [Related]
2.
Gong Y; Li S; Wang W; Li Y; Ma W; Sun S
Future Microbiol; 2019 Dec; 14():1545-1557. PubMed ID: 31992072
[No Abstract] [Full Text] [Related]
3. A semisynthetic borrelidin analogue BN-3b exerts potent antifungal activity against Candida albicans through ROS-mediated oxidative damage.
Su H; Hu C; Cao B; Qu X; Guan P; Mu Y; Han L; Huang X
Sci Rep; 2020 Mar; 10(1):5081. PubMed ID: 32193473
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
5. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans.
Sharma M; Manoharlal R; Puri N; Prasad R
Biosci Rep; 2010 Dec; 30(6):391-404. PubMed ID: 20017731
[TBL] [Abstract][Full Text] [Related]
6. Natural product solasodine-3-O-β-D-glucopyranoside inhibits the virulence factors of Candida albicans.
Li Y; Chang W; Zhang M; Ying Z; Lou H
FEMS Yeast Res; 2015 Sep; 15(6):. PubMed ID: 26162798
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus mutans sigX-inducing peptide inhibits the virulence of Candida albicans and oral candidiasis through the Ras1-cAMP-Efg1 pathway.
Zhang K; Sun IG; Liao B; Yang Y; Ma H; Jiang A; Chen S; Guo Q; Ren B
Int J Antimicrob Agents; 2023 Aug; 62(2):106855. PubMed ID: 37211262
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
Vila TV; Chaturvedi AK; Rozental S; Lopez-Ribot JL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7611-20. PubMed ID: 26416861
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
Ohta H; Tanimoto T; Taniai M; Taniguchi M; Ariyasu T; Arai S; Ohta T; Fukuda S
In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
[TBL] [Abstract][Full Text] [Related]
10. Dimethylaminododecyl methacrylate inhibits Candida albicans and oropharyngeal candidiasis in a pH-dependent manner.
Chen H; Zhou Y; Zhou X; Liao B; Xu HHK; Chu CH; Cheng L; Ren B
Appl Microbiol Biotechnol; 2020 Apr; 104(8):3585-3595. PubMed ID: 32125481
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of Candida albicans oral infection.
Shin SH; Lee YS; Shin YP; Kim B; Kim MH; Chang HR; Jang WS; Lee IH
J Antimicrob Chemother; 2013 May; 68(5):1152-60. PubMed ID: 23302580
[TBL] [Abstract][Full Text] [Related]
12. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans
Lei J; Huang J; Xin C; Liu F; Zhang J; Xie Y; Mao Y; Chen W; Song Z
Microbiol Spectr; 2023 Feb; 11(1):e0380122. PubMed ID: 36625571
[TBL] [Abstract][Full Text] [Related]
13. The Anti-Biofilm Efficacy of Caffeic Acid Phenethyl Ester (CAPE)
de Barros PP; Rossoni RD; Garcia MT; Kaminski VL; Loures FV; Fuchs BB; Mylonakis E; Junqueira JC
Front Cell Infect Microbiol; 2021; 11():700305. PubMed ID: 34408988
[No Abstract] [Full Text] [Related]
14. Hydroxychloroquine an Antimalarial Drug, Exhibits Potent Antifungal Efficacy Against Candida albicans Through Multitargeting.
Basrani ST; Gavandi TC; Patil SB; Kadam NS; Yadav DV; Chougule SA; Karuppayil SM; Jadhav AK
J Microbiol; 2024 May; 62(5):381-391. PubMed ID: 38587590
[TBL] [Abstract][Full Text] [Related]
15. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
16. 2-amino-nonyl-6-methoxyl-tetralin muriate activity against Candida albicans augments endogenous reactive oxygen species production --a microarray analysis study.
Liang RM; Yong XL; Jiang YP; Tan YH; Dai BD; Wang SH; Hu TT; Chen X; Li N; Dong ZH; Huang XC; Chen J; Cao YB; Jiang YY
FEBS J; 2011 Apr; 278(7):1075-85. PubMed ID: 21251230
[TBL] [Abstract][Full Text] [Related]
17. Holotoxin A
Liao M; Xia X; Meng Q; Zhu C; Liao B; Wang J; Gou L; Zhou X; Yuan W; Cheng L; Ren B
Br J Pharmacol; 2024 Jun; 181(12):1857-1873. PubMed ID: 38382564
[TBL] [Abstract][Full Text] [Related]
18. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
Sun L; Liao K; Wang D
PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
[TBL] [Abstract][Full Text] [Related]
19. Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo.
Lei S; Zhao H; Pang B; Qu R; Lian Z; Jiang C; Shao D; Huang Q; Jin M; Shi J
Appl Microbiol Biotechnol; 2019 Jun; 103(11):4377-4392. PubMed ID: 30997554
[TBL] [Abstract][Full Text] [Related]
20. Lipopeptides from Bacillus strain AR2 inhibits biofilm formation by Candida albicans.
Rautela R; Singh AK; Shukla A; Cameotra SS
Antonie Van Leeuwenhoek; 2014 May; 105(5):809-21. PubMed ID: 24623107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
